Although alterations in MED12 and HMGA2 seem to be mutually exclusive [143], whether these genetic alterations induce the transformation of myometrial stem cells or maintain already existing leiomyoma stem-progenitor cells remains unclear. The gene discussed is MED12; the disease is leiomyoma.